-+ 0.00%
-+ 0.00%
-+ 0.00%

Werewolf Therapeutics director Luke Evnin disposes of common shares worth $198,028.71

PUBT·05/04/2026 22:00:49
Listen to the news
Werewolf Therapeutics director Luke Evnin disposes of common shares worth $198,028.71
  • Luke Evnin, director, reported sales of 274,619 shares of Werewolf Therapeutics common stock in transactions dated April 30, May 1, May 4.
  • Shares sold at weighted average prices of $0.72, $0.73, $0.72.
  • Indirect beneficial ownership stood at 1,679,330 shares following latest sale.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Werewolf Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001134657-26-000008), on May 04, 2026, and is solely responsible for the information contained therein.